{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
QMS Medical Allied Services Ltd
QMS Medical Allied Services Ltd is Rated Sell
QMS Medical Allied Services Ltd is rated Sell by MarketsMOJO. This rating was last updated on 29 June 2026, reflecting a change from the previous Hold rating. However, all fundamentals, returns, and financial metrics discussed here are current as of 04 July 2026, providing investors with the latest assessment of the stock’s position.
Golden Cross Forms in QMS Medical Allied Services Ltd — On a Day the Stock Rose 2.26%. What the Mixed Signals Mean
The 50-day moving average has crossed above the 200-day moving average for QMS Medical Allied Services Ltd, signalling a golden cross on 2 Jul 2026. Yet, the broader technical and fundamental context presents a nuanced picture that tempers the enthusiasm this crossover might otherwise inspire.
QMS Medical Allied Services Ltd is Rated Hold
QMS Medical Allied Services Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 June 2026, providing investors with the latest insights into its performance and outlook.
QMS Medical Allied Services Gains 5.84%: Valuation Shift and Earnings Impact Key
QMS Medical Allied Services Ltd closed the week with a notable gain of 5.84%, outperforming the Sensex which declined by 0.78%. The stock’s recovery followed a challenging start to the week marked by profit declines and margin pressures, but was supported by a positive reassessment of valuation metrics midweek. Despite early weakness, the stock demonstrated resilience with strong gains on the final two trading days, reflecting renewed investor interest amid valuation recalibration.
QMS Medical Allied Services Ltd is Rated Sell
QMS Medical Allied Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
QMS Medical Allied Services Ltd: Valuation Shifts Signal Renewed Price Attractiveness
QMS Medical Allied Services Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. This change reflects evolving market perceptions and improved price metrics relative to its historical averages and peer group, offering investors a fresh perspective on the stock’s price attractiveness amid a challenging healthcare services sector.
Are QMS Medical Allied Services Ltd latest results good or bad?
QMS Medical Allied Services Ltd's latest results indicate challenges, with a slight revenue recovery but a significant 48.50% decline in net profit and the lowest operating margin in eight quarters, raising concerns about profitability and financial sustainability due to rising debt and operational costs.
QMS Medical Allied Services Q4 FY26: Profit Plunge and Margin Compression Signal Troubling Times
QMS Medical Allied Services Ltd., a medical products distribution company with a market capitalisation of ₹170.00 crores, reported deeply concerning results for Q4 FY26, with consolidated net profit plummeting 48.50% year-on-year to ₹1.72 crores from ₹3.34 crores in the same quarter last year. The sequential decline was equally alarming, with profit falling 28.33% from ₹2.40 crores in Q3 FY26, marking the company's weakest quarterly performance in over two years.
QMS Medical Allied Services Ltd is Rated Sell
QMS Medical Allied Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Are QMS Medical Allied Services Ltd latest results good or bad?
QMS Medical Allied Services Ltd's latest Q3 FY26 results show a decline in net profit by 23.08% quarter-on-quarter and 17.81% year-on-year, with revenue dropping 16.64% from the previous quarter, marking the lowest performance in eight quarters. Despite improved operating margins, rising interest expenses and a lower interest coverage ratio raise concerns about the company's financial health.
QMS Medical Allied Services Ltd is Rated Sell
QMS Medical Allied Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.
QMS Medical Allied Services Ltd is Rated Sell
QMS Medical Allied Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Feb 2026. However, the analysis below reflects the stock's current position as of 09 May 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective.
QMS Medical Allied Services Ltd is Rated Sell
QMS Medical Allied Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the latest comprehensive analysis.
QMS Medical Allied Services Ltd is Rated Sell
QMS Medical Allied Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
QMS Medical Allied Services Ltd is Rated Sell
QMS Medical Allied Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trend, and technical outlook.
QMS Medical Allied Services Ltd is Rated Sell
QMS Medical Allied Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with the most up-to-date view of the company’s performance and outlook.
QMS Medical Allied Services Ltd is Rated Sell
QMS Medical Allied Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
QMS Medical Allied Services Ltd is Rated Sell
QMS Medical Allied Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
QMS Medical Allied Services Ltd Declines 0.74% Despite Valuation Appeal: 5 Key Weekly Developments
QMS Medical Allied Services Ltd experienced a modest decline of 0.74% over the week ending 20 Feb 2026, closing at Rs.87.65. This performance contrasted with the Sensex’s 0.39% gain during the same period, reflecting a mixed market response amid operational headwinds and valuation recalibrations. The stock’s week was marked by a strong start on 16 Feb with a 5.04% gain following Q3 results, followed by subdued trading and a gradual pullback as the week progressed.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
